New leadership at European PCI association
This article was originally published in Clinica
Executive Summary
Professor Carlo Di Mario has been elected president of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), part of the European Society of Cardiology (ESC), at the end of this month. He formally replaces William Wijns on August 31, during the two-year-old association's general assembly. EAPCI, in collaboration with European medtech industry association Eucomed, recently launched the "Stent for Life" initiative. Its mission is to "improve the delivery and patient access to the life saving indications of percutaneous cardiovascular interventions, thereby reducing the mortality and morbidity of patients suffering from acute coronary syndromes".
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.